CAI Stock Analysis: Buy, Sell, or Hold?
CAI - Caris Life Sciences, Inc. Common Stock
$23.16
-2.04 (-8.10%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 04, 2026
4d
Get Alerted When CAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CAI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CAI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CAI is currently trading at $23.16, which is considered oversold relative to its 30-day fair value range of $25.48 to $28.13.
Technical Outlook: Technically, CAI is in a strong downtrend. The price is currently testing key support at $23.14. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 8.1% recently.
Market Sentiment: CAI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CAI is in a strong downtrend. The price is currently testing key support at $23.14. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 8.1% recently.
Market Sentiment: CAI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$25.48 -
$28.13
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.1%
Protect Your Profits
Holding CAI? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.1%)
- CAUTION: 5-day price weakness (-7.4%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$25.48 -
$28.13
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$23.14
Resistance Level
$27.33
Current Trend
Strong Downtrend
Fundamental Context
Revenue Growth (YoY)
49.9%
Profit Margin
-60.4%
Last updated: January 30, 2026 5:41 PM ET
Data refreshes hourly during market hours. Next update: 6:41 PM
Data refreshes hourly during market hours. Next update: 6:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced CAI Option Strategies
Professional options setups generated by AI based on today's CAI price and gamma walls.